
views
Accrol – ‘successfully navigating inflationary pressures and well positioned’. Really?...
A “Trading Update - FY22 in line with expectations”-titled announcement from tissue converter group Accrol (ACRL) sounds good given the current macro climate. So what of a current 26p share price?...
- By Steve Moore
- 2022-05-17 15:54:43